Overview

Raltegravir Insulin Sensitivity Study

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to look at the effects of two different HIV medications on the body's response to insulin (a hormone that regulates blood sugar levels). This will be done using a method called the 'euglycaemic clamp' The study will also investigate the effects of these drugs on blood fats and on circulating markers in the blood stream related to blood vessels (vascular inflammation markers).
Phase:
Phase 1
Details
Lead Sponsor:
St Stephens Aids Trust
Treatments:
Insulin
Lopinavir
Raltegravir Potassium
Ritonavir